Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00441155
Status:
COMPLETED
Last Update Posted:
2013-05-13
First Post:
2007-02-26
Brief Title:
Patients Completing Core Protocol CAMN107A2103 Exhibiting Stable Disease SD Partial Response PR or Complete Response CR to Nilotinib in Combination With Imatinib
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11
Start Date Type:
None
Primary Completion Date:
2011-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-01
Completion Date Type:
ACTUAL
First Submit Date:
2007-02-26
First Submit QC Date:
February 27 2007
Study First Post Date:
2007-02-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-05-09
Last Update Post Date:
2013-05-13
Last Update Post Date Type:
ESTIMATED